Murad Rapid Dark Spot Correcting Serum vs La Roche-Posay Mela B3 Serum

Murad's published formula leads with patented resorcinol technology and tranexamic acid, two pigment pathway ingredients, and adds glycolic acid as a true resurfacing acid. Mela B3 leads with Melasyl, a single purpose patented molecule, beside 10 percent niacinamide, and its surface work is done by capryloyl salicylic acid, the gentle LHA that pharmacy brands use where glycolic would be too much. In practical terms: Murad changes how the surface feels as well as how spots look; Mela B3 stays quieter on texture and concentrates on tone.

Mela B3 prints its niacinamide level on the bottle in large type and publishes its study horizon of eight weeks. Murad prints neither percentages nor a timeline, and argues from architecture instead: three named routes, unpublished strengths. A reader who buys by the label will feel more at home with the purple bottle. A reader who buys by formula design will find Murad's three route case persuasive despite the silence. Neither bottle prints everything; they simply choose different things to be silent about, since Melasyl's own level is also unpublished.

Murad is an airless pump in a once or twice daily slot that must be negotiated with the rest of an acid carrying routine. Mela B3 is a dropper dosed at 3 to 4 drops, directed morning and evening, with a companion sunscreen in its own line. The scent ledger also differs in kind: Murad's listing emphasises what the formula leaves out, parabens, sulfates and phthalates, while Mela B3's specifications state plainly that the serum is scented, the fact most likely to decide the purchase for fragrance sensitive readers.